PL2531218T3 - Preparat immunoglobuliny - Google Patents

Preparat immunoglobuliny

Info

Publication number: PL2531218T3
Authority: PL; Poland
Prior art keywords: immunoglobulin preparation; immunoglobulin; preparation
Prior art date: 2010-02-04

Application number

PL11702054T

Other languages

English (en)

Inventor

Reinhard Franz Bolli

Werner Maeder

Peter Lerch

Original Assignee

Csl Behring Ag

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2010-02-04

Filing date

2011-02-03

Publication date

2019-05-31

Family has litigation

First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=42211669&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=PL2531218(T3) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.

2011-02-03 Application filed by Csl Behring Ag filed Critical Csl Behring Ag

2019-05-31 Publication of PL2531218T3 publication Critical patent/PL2531218T3/pl

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/22—Heterocyclic compounds, e.g. ascorbic acid, tocopherol or pyrrolidones
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/395—Antibodies; Immunoglobulins; Immune serum, e.g. antilymphocytic serum
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/395—Antibodies; Immunoglobulins; Immune serum, e.g. antilymphocytic serum
- A61K39/39533—Antibodies; Immunoglobulins; Immune serum, e.g. antilymphocytic serum against materials from animals
- A61K39/39566—Antibodies; Immunoglobulins; Immune serum, e.g. antilymphocytic serum against materials from animals against immunoglobulins, e.g. anti-idiotypic antibodies
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/16—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing nitrogen, e.g. nitro-, nitroso-, azo-compounds, nitriles, cyanates
- A61K47/18—Amines; Amides; Ureas; Quaternary ammonium compounds; Amino acids; Oligopeptides having up to five amino acids
- A61K47/183—Amino acids, e.g. glycine, EDTA or aspartame
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies

Landscapes

Health & Medical Sciences (AREA)
Chemical & Material Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Medicinal Chemistry (AREA)
General Health & Medical Sciences (AREA)
Public Health (AREA)
Pharmacology & Pharmacy (AREA)
Animal Behavior & Ethology (AREA)
Veterinary Medicine (AREA)
Epidemiology (AREA)
Engineering & Computer Science (AREA)
Organic Chemistry (AREA)
Proteomics, Peptides & Aminoacids (AREA)
Immunology (AREA)
Chemical Kinetics & Catalysis (AREA)
General Chemical & Material Sciences (AREA)
Oil, Petroleum & Natural Gas (AREA)
Biophysics (AREA)
Genetics & Genomics (AREA)
Molecular Biology (AREA)
Biochemistry (AREA)
Bioinformatics & Cheminformatics (AREA)
Dermatology (AREA)
Microbiology (AREA)
Mycology (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Medicinal Preparation (AREA)
Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
Peptides Or Proteins (AREA)

PL11702054T 2010-02-04 2011-02-03 Preparat immunoglobuliny PL2531218T3 (pl)

Applications Claiming Priority (3)

Application Number	Priority Date	Filing Date	Title
EP10001164		2010-02-04
EP11702054.5A EP2531218B1 (en)	2010-02-04	2011-02-03	Immunoglobulin preparation
PCT/EP2011/051556 WO2011095543A1 (en)	2010-02-04	2011-02-03	Immunoglobulin preparation

Publications (1)

Publication Number	Publication Date
PL2531218T3 true PL2531218T3 (pl)	2019-05-31

Family

ID=42211669

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
PL11702054T PL2531218T3 (pl)	2010-02-04	2011-02-03	Preparat immunoglobuliny

Country Status (12)

Country	Link
US (4)	US9241897B2 (pl)
EP (1)	EP2531218B1 (pl)
JP (2)	JP6078344B2 (pl)
KR (1)	KR101912169B1 (pl)
CN (1)	CN102753197B (pl)
AU (1)	AU2011212440B2 (pl)
CA (1)	CA2788863C (pl)
DK (1)	DK2531218T3 (pl)
ES (1)	ES2716088T3 (pl)
PL (1)	PL2531218T3 (pl)
TR (1)	TR201903403T4 (pl)
WO (1)	WO2011095543A1 (pl)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
EP1532983A1 (en)	2003-11-18	2005-05-25	ZLB Bioplasma AG	Immunoglobulin preparations having increased stability
EP2531218B1 (en) *	2010-02-04	2018-12-12	CSL Behring AG	Immunoglobulin preparation
EP2361636A1 (en)	2010-02-26	2011-08-31	CSL Behring AG	Immunoglobulin preparation and storage system for an immunoglobulin preparation
EP3058952A1 (en) *	2011-04-07	2016-08-24	Glaxosmithkline LLC	Formulations with reduced viscosity
KR101759694B1 (ko)	2011-10-28	2017-07-19	인테그리티 바이오, 아이엔씨.	아미노산을 함유하는 단백질 제제
AU2014223679B2 (en) *	2013-02-26	2018-11-29	Takeda Pharmaceutical Company Limited	Treatment of central nervous system disorders by intranasal administration of immunoglobulin G
JP6179939B2 (ja) *	2013-07-09	2017-08-16	国立大学法人筑波大学	高濃度γグロブリン製剤の粘度低下方法
SG10201913952TA (en)	2013-09-11	2020-03-30	Eagle Biologics Inc	Liquid protein formulations containing viscosity-lowering agents
ES2902689T3 (es)	2014-04-03	2022-03-29	Csl Behring Ag	Nebulización de inmunoglobulina
SG11201702614SA (en)	2014-10-01	2017-04-27	Eagle Biolog Inc	Polysaccharide and nucleic acid formulations containing viscosity-lowering agents
AU2015335743B2 (en) *	2014-10-23	2020-12-24	Amgen Inc.	Reducing viscosity of pharmaceutical formulations
CN109937034B (zh) *	2016-11-21	2022-09-16	济世-伊沃泰克生物制品有限公司	阿柏西普制剂及其用途
BR112021009572A2 (pt)	2018-11-30	2021-08-17	Csl Behring Ag	métodos e composições para prevenção ou tratamento de exacerbações agudas com imunoglobulina policlonal

Family Cites Families (55)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
DE2364792A1 (de)	1973-01-15	1974-07-18	South African Inventions	Verfahren zum reinigen von gammaglobulin
JPS5420124A (en)	1977-07-14	1979-02-15	Green Cross Corp:The	Preparation of gamma-globulin intravenous injection
US4186192A (en)	1978-12-18	1980-01-29	Cutter Laboratories, Inc.	Stabilized immune serum globulin
US4362661A (en)	1979-08-09	1982-12-07	Teijin Limited	Immunoglobulin composition having a high monomer content, and process for production thereof
JPS5731623A (en)	1980-07-30	1982-02-20	Morishita Seiyaku Kk	Production of gamma-globulin for intravenous injection
JPS56127321A (en)	1980-03-10	1981-10-06	Mochida Pharmaceut Co Ltd	Preparation of gamma-globulin pharmaceutical
JPS56135418A (en)	1980-03-27	1981-10-22	Green Cross Corp:The	Heat treatment of aqueous solution containing 8 factor of coagulation of blood derived from human
JPS57128635A (en)	1981-01-30	1982-08-10	Morishita Seiyaku Kk	Pharmaceutical preparation of gamma-globulin for venoclysis
US4360451A (en)	1981-08-10	1982-11-23	Basf Wyandotte Corporation	Amphoteric surfactant gels
US4499073A (en)	1981-08-24	1985-02-12	Cutter Laboratories, Inc.	Intravenously injectable immune serum globulin
US4396608A (en)	1981-08-24	1983-08-02	Cutter Laboratories	Intravenously injectable immune serum globulin
US4439421A (en)	1982-08-30	1984-03-27	Baxter Travenol Laboratories, Inc.	Stabilized gamma globulin concentrate
JPS6042336A (ja)	1983-08-18	1985-03-06	Nippon Seiyaku Kk	免疫グロブリンの製造方法
JPS60120823A (ja)	1983-12-02	1985-06-28	Green Cross Corp:The	ＩｇＧ単量体
US4597966A (en)	1985-01-09	1986-07-01	Ortho Diagnostic Systems, Inc.	Histidine stabilized immunoglobulin and method of preparation
JPH0825902B2 (ja)	1985-02-21	1996-03-13	株式会社ミドリ十字	γ−グロブリンの加熱処理方法
JPH0825903B2 (ja)	1985-05-16	1996-03-13	株式会社ミドリ十字	γ―グロブリン含有水溶液
GB8628104D0 (en)	1986-11-25	1986-12-31	Connaught Lab	Pasteurization of immunoglobin solutions
DE3641115A1 (de)	1986-12-02	1988-06-16	Lentia Gmbh	Verfahren zur herstellung eines intravenoes anwendbaren und in fluessiger form stabilen immunglobulins
CA2013600A1 (en)	1989-04-04	1990-10-04	Michael J. Pikal	Pharmaceutical formulations
JPH0341033A (ja)	1989-07-07	1991-02-21	Kyowa Hakko Kogyo Co Ltd	安定なモチリン類含有製剤
US5945098A (en)	1990-02-01	1999-08-31	Baxter International Inc.	Stable intravenously-administrable immune globulin preparation
US5177194A (en)	1990-02-01	1993-01-05	Baxter International, Inc.	Process for purifying immune serum globulins
DE59009020D1 (de)	1990-03-22	1995-06-08	Biotest Pharma Gmbh	Verfahren zur Herstellung eines intravenös verträglichen Immunglobulin-G-Präparates.
JPH04346934A (ja)	1991-05-24	1992-12-02	Green Cross Corp:The	γ−グロブリンの液状製剤
DE4118912C1 (pl)	1991-06-08	1992-07-02	Biotest Pharma Gmbh, 6072 Dreieich, De
DE4126983A1 (de)	1991-08-15	1993-02-18	Boehringer Mannheim Gmbh	Verfahren zur herstellung von humanprotein-enthaltenden, konservierten arzneimitteln fuer infusions- oder injektionszwecke
JP2942412B2 (ja)	1991-12-26	1999-08-30	鐘紡株式会社	化粧料
FR2706466B1 (fr)	1993-06-14	1995-08-25	Aetsrn	Concentré d'immunoglobulines G à usage thérapeutique et procédé de production dudit concentré.
ES2129076T5 (es)	1993-12-27	2003-05-16	Zlb Bioplasma Ag	Procedimiento para la preparacion de un concentrado de inmunoglobulina g anti-d y composicion farmaceutica que lo contiene.
JPH07238036A (ja)	1994-02-28	1995-09-12	Green Cross Corp:The	静注用グロブリン液状組成物のグロブリン二量体増加抑制方法
GB9418092D0 (en)	1994-09-08	1994-10-26	Red Cross Found Cent Lab Blood	Organic compounds
JP3765108B2 (ja)	1994-09-30	2006-04-12	三菱ウェルファーマ株式会社	静脈注射用グロブリン製剤
EP0792294A1 (en)	1994-11-16	1997-09-03	Baxter International Inc.	Human antibodies to t-cell receptor peptides and methods for their preparation
GB9610992D0 (en)	1996-05-24	1996-07-31	Glaxo Group Ltd	Concentrated antibody preparation
TW491855B (en)	1996-08-07	2002-06-21	Csl Ltd	Purification of immunoglobulins
EP0852951A1 (de)	1996-11-19	1998-07-15	Roche Diagnostics GmbH	Stabile lyophilisierte pharmazeutische Zubereitungen von mono- oder polyklonalen Antikörpern
BR9714434A (pt)	1996-12-24	2000-05-02	Biogen Inc	Formulações de interferon liquidas estáveis
US6171586B1 (en)	1997-06-13	2001-01-09	Genentech, Inc.	Antibody formulation
US5886154A (en)	1997-06-20	1999-03-23	Lebing; Wytold R.	Chromatographic method for high yield purification and viral inactivation of antibodies
CA2251342A1 (en)	1997-10-23	1999-04-23	Yutaka Hirao	Room temperature storable immunoglobulin preparation for intravenous injection
US6162904A (en)	1997-12-24	2000-12-19	Alpha Therapeutic Corporation	Manufacturing method for intraveneously administrable immune globulin and resultant product
CA2330170C (en)	1998-06-09	2010-11-02	Statens Serum Institut	Process for producing immunoglobulins for intravenous administration and other immunoglobulin products
SE0001128D0 (sv)	2000-03-30	2000-03-30	Amersham Pharm Biotech Ab	A method of producing IgG
US6887462B2 (en)	2001-04-09	2005-05-03	Chiron Corporation	HSA-free formulations of interferon-beta
GB0113179D0 (en)	2001-05-31	2001-07-25	Novartis Ag	Organic compounds
WO2004084816A2 (en)	2003-03-21	2004-10-07	Progenics Pharmaceuticals, Inc.	IMPROVED CD4-IgG2 FORMULATIONS
US20050075611A1 (en) *	2003-10-01	2005-04-07	Hetzler Kevin G.	Low extractable, thermoplastic syringe and tip cap
EP1532983A1 (en)	2003-11-18	2005-05-25	ZLB Bioplasma AG	Immunoglobulin preparations having increased stability
US20060051347A1 (en)	2004-09-09	2006-03-09	Winter Charles M	Process for concentration of antibodies and therapeutic products thereof
KR20090060453A (ko)	2006-09-25	2009-06-12	메디뮨 엘엘씨	안정화된 항체 제제 및 그것의 용도
KR101441768B1 (ko)	2009-09-17	2014-09-17	박스터 헬쓰케어 에스에이	히알루로니다아제 및 면역글로불린의 안정한 복합제제, 및 그 사용방법
UA112288C2 (uk)	2010-01-15	2016-08-25	Кірін-Емджен, Інк.	Склад антитіла, що специфічно зв'язує рецептор а іl-17, і терапевтичні режими
EP2531218B1 (en) *	2010-02-04	2018-12-12	CSL Behring AG	Immunoglobulin preparation
EP2361636A1 (en)	2010-02-26	2011-08-31	CSL Behring AG	Immunoglobulin preparation and storage system for an immunoglobulin preparation

2011
- 2011-02-03 EP EP11702054.5A patent/EP2531218B1/en active Active
- 2011-02-03 CN CN201180008195.9A patent/CN102753197B/zh active Active
- 2011-02-03 AU AU2011212440A patent/AU2011212440B2/en active Active
- 2011-02-03 PL PL11702054T patent/PL2531218T3/pl unknown
- 2011-02-03 ES ES11702054T patent/ES2716088T3/es active Active
- 2011-02-03 KR KR1020127022986A patent/KR101912169B1/ko active IP Right Grant
- 2011-02-03 JP JP2012551619A patent/JP6078344B2/ja active Active
- 2011-02-03 WO PCT/EP2011/051556 patent/WO2011095543A1/en active Application Filing
- 2011-02-03 DK DK11702054.5T patent/DK2531218T3/en active
- 2011-02-03 TR TR2019/03403T patent/TR201903403T4/tr unknown
- 2011-02-03 US US13/577,220 patent/US9241897B2/en active Active
- 2011-02-03 CA CA2788863A patent/CA2788863C/en not_active Expired - Fee Related
2015
- 2015-12-15 US US14/970,326 patent/US10137197B2/en active Active
2016
- 2016-01-15 JP JP2016005818A patent/JP2016106108A/ja active Pending
2018
- 2018-06-15 US US16/009,670 patent/US20180360969A1/en not_active Abandoned
2021
- 2021-10-29 US US17/514,957 patent/US20220118092A1/en active Pending

Also Published As

Publication number	Publication date
DK2531218T3 (en)	2019-04-01
WO2011095543A1 (en)	2011-08-11
KR101912169B1 (ko)	2018-10-26
KR20120125512A (ko)	2012-11-15
EP2531218A1 (en)	2012-12-12
CN102753197A (zh)	2012-10-24
US20220118092A1 (en)	2022-04-21
JP2013518852A (ja)	2013-05-23
AU2011212440B2 (en)	2015-01-22
ES2716088T3 (es)	2019-06-10
CA2788863A1 (en)	2011-08-11
US20120308557A1 (en)	2012-12-06
TR201903403T4 (tr)	2019-04-22
US20160151495A1 (en)	2016-06-02
US9241897B2 (en)	2016-01-26
JP6078344B2 (ja)	2017-02-08
CA2788863C (en)	2020-07-07
AU2011212440A1 (en)	2012-08-16
CN102753197B (zh)	2014-05-14
US10137197B2 (en)	2018-11-27
US20180360969A1 (en)	2018-12-20
JP2016106108A (ja)	2016-06-16
EP2531218B1 (en)	2018-12-12

Publication	Publication Date	Title
HRP20180952T1 (hr)	2018-07-27	Anti-dll3 antitijelo
ZA201701051B (en)	2018-05-30	Neutralizing anti-ccl20 antibodies
ZA201209004B (en)	2013-08-28	Anti-fgfr2 antibodies
GB201000467D0 (en)	2010-02-24	Antibodies
IL221371A0 (en)	2012-10-31	Anti-lrp6 antibodies
HUE040213T2 (hu)	2019-02-28	Anti-TIM antitest
PL2616489T3 (pl)	2017-07-31	Przeciwciało anty-huTNFR1
GB201113558D0 (en)	2011-09-21	Kraftfahrzeugkarosserie mit strukturverstarkter vorderrahmenanbindung
IL225667A0 (en)	2013-06-27	A new antigen
PL2531218T3 (pl)	2019-05-31	Preparat immunoglobuliny
GB201020738D0 (en)	2011-01-19	Antibodies
HK1194388A1 (zh)	2014-10-17	抗缺刻蛋白抗體
PL2603528T3 (pl)	2017-07-31	Przeciwciała Fab-glikozylowane
GB201116180D0 (en)	2011-11-02	Kraftfahrzeug mit warnsystem
GB201002238D0 (en)	2010-03-31	Antibodies
ZA201302459B (en)	2014-01-29	Antibodies
EP2550961A4 (en)	2013-08-07	SOLID PREPARATION
EP2550960A4 (en)	2013-08-28	SOLID PREPARATION
GB201007957D0 (en)	2010-06-30	Antibody
GB201009684D0 (en)	2010-07-21	Odontalgic preparation
AU4932P (en)	2014-10-21	FlatwaxpinkGL Chamelaucium uncinatum
GB201020751D0 (en)	2011-01-19	Antibodies
GB201005062D0 (en)	2010-05-12	Antibodies
GB201017780D0 (en)	2010-12-01	Antibody
IL226635B (en)	2019-09-26	Human anti-sod1 antibodies